Latest Funding News

Forrestania Resources has updated the opening date of its Share Purchase Plan to 9 December 2025, aligning it with key corporate events and offering shareholders a chance to buy shares at $0.175 each alongside new option incentives.

Great Divide Mining Ltd has agreed to acquire the remaining 49% stake in Challenger Mines Pty Ltd from Adelong Gold Limited, aiming to resolve a protracted joint venture dispute and restart operations at the Challenger Gold Mine.

Sea Forest Limited launches a $20.5 million IPO on the ASX to scale production and commercialisation of SeaFeed™, a scientifically validated livestock feed additive that cuts methane emissions by up to 80% while boosting productivity.

Euroz Hartleys Group Limited reported a robust FY2025 with an 87.7% jump in net profit and a strong start to FY2026, driven by increased brokerage and capital markets activity.

Sequoia Financial Group has acknowledged that ASIC’s civil penalty proceedings against its subsidiary InterPrac are material and confirmed timely disclosure to the market following formal notification.

Andromeda Metals has initiated early site works at its Great White Project following the lodgement of a $3.79 million rehabilitation bond and environmental compliance payments. This milestone marks a key step toward advancing the project’s development in South Australia.

Rox Resources (ASX – RXL) has delivered a comprehensive update on its Youanmi Gold Project, highlighting a compelling Definitive Feasibility Study and significant funding progress that set the stage for production in 2026.

Comms Group has secured a new $10.7 million refinancing package with improved terms, including additional funding capacity for acquisitions and equipment finance. This move aims to enhance financial flexibility and support future growth initiatives.

Skylark Minerals has acquired a high-grade gold portfolio in Côte d'Ivoire, including a flagship project with a 364,600-ounce inferred resource, marking a significant step in its West African growth strategy. The company is fully funded to accelerate exploration in early 2026, targeting resource expansion and new discoveries.

Genmin Limited has successfully completed the first tranche of its capital raising, issuing over 131 million shares to fund its flagship Baniaka iron ore project in Gabon, targeting production by late 2026.

Chimeric Therapeutics has received a $4.5 million R&D tax incentive refund from the Australian Government, underscoring its ongoing investment in innovative cancer cell therapies.

VHM Limited has raised A$10.3 million through a fully-underwritten institutional placement, advancing its Goschen Project development ahead of a Final Investment Decision in early 2026. A Share Purchase Plan will follow, inviting existing shareholders to participate at the same discounted price.